Avadel Pharmaceuticals plc
US ˙ NasdaqGM ˙ US05337M1045
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAVDL / Avadel Pharmaceuticals plc
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership49,759 shares
Latest Disclosed Value $ 635,920
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 30.89% increase in ownership of AVDL / Avadel Pharmaceuticals plc

On April 24, 2024 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 49,759 shares of Avadel Pharmaceuticals plc (US:AVDL) valued at $635,920 USD as of February 29, 2024. The entity filed a previous NPORT-P on January 24, 2024 disclosing 38,015 shares of Avadel Pharmaceuticals plc. This represents a change in shares of 30.89% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2024-04-24 2024-02-29 NP AVADEL PHARMACEUTICALS PLC SPN ADR EC US05337M1045 49,759 11,744 30.89 636 44.98 0.0106
2024-01-24 2023-11-30 NP AVADEL PHARMACEUTICALS PLC SPN ADR EC US05337M1045 38,015 -2,132 -5.31 439 -19.19 0.0084
2023-10-27 2023-08-31 NP AVADEL PHARMACEUTICALS PLC SPN ADR EC US05337M1045 40,147 630 1.59 542 -0.91 0.0106
2023-07-26 2023-05-31 NP AVADEL PHARMACEUTICALS PLC SPN ADR EC US05337M1045 39,517 126 0.32 547 39.90 0.0118
2023-04-27 2023-02-28 NP AVADEL PHARMACEUTICALS PLC SPN ADR EC US05337M1045 39,391 945 2.46 392 11.08 0.0096
2023-01-26 2022-11-30 NP AVADEL PHARMACEUTICALS PLC SPN ADR EC US05337M1045 38,446 38,446 353 0.0088
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.